Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Relay Therapeutics, Inc. (RLAY)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| | 10-K | 10-K | 10-K | 10-K | S-1/A |
| Revenues | 100.0% | 100.0% | 100.0% | | |
| Cost of goods sold | 0.0% | 0.0% | 0.0% | | |
| Gross profit | 100.0% | 100.0% | 100.0% | | |
| Selling, general and administrative | 21770.9% | 12140.2% | 167.5% | | |
| Research and development | 17838.9% | 5699.9% | 120.8% | | |
| EBIT | -21670.9% | -7979.5% | -67.5% | | |
| Pre-tax income | -21036.1% | -12012.9% | -63.4% | | |
| Income taxes | 0.0% | 0.0% | 0.0% | | |
| Net income | -21036.1% | -12012.9% | -63.4% | | |
|